fda warning letter compounding semaglutide news 🚨 Moves to Permanently Shut Down Compounded GLP-1s The FDA is taking steps to eliminate large-scale of GLP-1 medications like and tirzepatide, signaling a major shift in how these Compounded "semaglutide" is not FDA-approved

Nov 26 2020;17(23)doi:10.3390/ijerph17238802

Activation of caspase-1 by inflammasomes induces pyroptosis, an inflammatory form of programmed cell death (Wroska et al., 2024)

Purifying long peptides is difficult, plus these GLP-1 peptide drugs have been modified to include a fatty acid side chain, and lipids themselves can be very difficult to purify, because theyre very hydrophobic, and tend to stick to the [purification] column, says Levine

Add on glutathione iv push to your iv treatment today for an antioxidant boost

Freezing and thawing can cause the peptide to aggregate and lose its structure, potentially rendering it inactive or altering its absorption characteristics

Use comfort-first textures and add soothing/barrier supports Provide a start slow plan for sensitive users Avoid asking consumers to stack too many strong actives at once 5